Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH Supplementation for Blastocyst Euploidy in AMA Patients
NCT05574894Phase 3Completed
- Sponsor
- Shanghai Ji Ai Genetics & IVF Institute
- Start
- Jan 2021
- Primary completion
- Jun 2022
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, open-label trial of somatropin in infertility (2 arms), sponsored by Shanghai Ji Ai Genetics & IVF Institute. Primary endpoint: Proportion of cycles which obtained euploid blastocysts. Started Jan 2021; status: completed.
02
Drugs
somatropin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05574894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05574894.